Login / Signup

Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.

Matteo PiccicaMichele SpinicciAnnarita BottaVincenzo BiancoFilippo LagiLucia GrazianiAlessandro FaragonaRoberto ParrellaTommaso GianiAndrea BartoliniGianluca MorroniMariano BernardoGian Maria RossoliniMarcello TavioAndrea GiacomettiAlessandro Bartoloni
Published in: The Journal of antimicrobial chemotherapy (2023)
Real-life data confirm that cefiderocol is a promising option against carbapenem-resistant Gram-negative infections, even as monotherapy.
Keyphrases
  • gram negative
  • multidrug resistant
  • combination therapy
  • clinical trial
  • electronic health record
  • study protocol
  • open label
  • big data
  • cross sectional
  • double blind
  • replacement therapy